Carmine N. Stengone
President, CEO & DirectorMr. Carmine N. Stengone, MS, MBA, serves as Chief Executive Officer, President & Director of Contineum Therapeutics, Inc. since October 2018 and served as its Secretary and served as its Chairman of the Board until March 2024. He serves as Independent Director at Kiora Pharmaceuticals, Inc. since August 2023 and serves as its Chairman of the Board. He served as Chief Executive Officer of Avelas BioSciences, Inc. since January 2014 and served as its President. Mr. Stengone served as Chief Business Officer and Senior Vice President of Business Development of COI Pharmaceuticals Inc. Mr. Stengone served as Chief Executive Officer and President of Afraxis, Inc. since April 2013 and serves as its Director. He joined Avelas BioSciences, Inc. in 2012 as Chief Business Officer. Mr. Stengone served as Vice President of Corporate Development at Afraxis, Inc. since March 2010 until April 2013. Mr. Stengone served as Senior Director of Business Development of Phenomix Corporation from January 2009 to 2010. He served as the Head of Business Development/Corporate Development at Afraxis, Inc. He joined Phenomix in August 2006 as Director of Business Development. Prior to joining Phenomix, he served as Senior Manager of Business Development and Strategic Marketing for Anadys Pharmaceuticals, Inc. since joining in September 2004 until 2006. From May 2003 to September 2004, Mr. Stengone served as Manager of Licensing & Acquisition Finance and Strategic Planning at Johnson & Johnson Pharmaceutical Research and Development, L.L.C. He has been a Director of Avelas BioSciences since January 2014. He holds a B.S. in chemistry from Wake Forest University in 1997. He received a MS in Organic Chemistry from the Duke University in 1999 and an MBA from the S.C. Johnson Graduate School of Management at Cornell University in 2003.
Positions
- Company NameContineum Therapeutics, Inc.Stock CodeCTNMPositionPresident, CEO & DirectorColleagues
- EBEvert B. SchimmelpenninkIndependent Chairman of the Board
- PTPeter T. SloverChief Financial Officer
- TRTimothy R. WatkinsChief Medical Officer & Head of Development
- MPMorgan PaulsenSenior Manager of Accounting
- DSDaniel S. LorrainChief Science Officer
- TRTodd R. BradyIndependent Director
- TATroy A. IgnelziIndependent Director
- SBSarah BoyceIndependent Director
